| 000 | 01579 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250514182813.0 | ||
| 264 | 0 | _c20040511 | |
| 008 | 200405s 0 0 eng d | ||
| 022 | _a0035-3787 | ||
| 024 | 7 |
_a10.1016/s0035-3787(04)70888-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNewsom-Davis, J | |
| 245 | 0 | 0 |
_aLambert-Eaton myasthenic syndrome. _h[electronic resource] |
| 260 |
_bRevue neurologique _cFeb 2004 |
||
| 300 |
_a177-80 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_a4-Aminopyridine _xanalogs & derivatives |
| 650 | 0 | 4 | _aAmifampridine |
| 650 | 0 | 4 |
_aAutoantibodies _ximmunology |
| 650 | 0 | 4 |
_aAutoantigens _ximmunology |
| 650 | 0 | 4 |
_aAutoimmune Diseases of the Nervous System _xdiagnosis |
| 650 | 0 | 4 |
_aCalcium Channels, P-Type _ximmunology |
| 650 | 0 | 4 |
_aCalcium Channels, Q-Type _ximmunology |
| 650 | 0 | 4 |
_aCarcinoma, Small Cell _xcomplications |
| 650 | 0 | 4 |
_aCholinesterase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulins, Intravenous _xtherapeutic use |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aLambert-Eaton Myasthenic Syndrome _xdiagnosis |
| 650 | 0 | 4 |
_aLung Neoplasms _xcomplications |
| 650 | 0 | 4 |
_aNeoplasm Proteins _ximmunology |
| 650 | 0 | 4 | _aPlasmapheresis |
| 650 | 0 | 4 |
_aPotassium Channel Blockers _xtherapeutic use |
| 650 | 0 | 4 |
_aPyridostigmine Bromide _xtherapeutic use |
| 773 | 0 |
_tRevue neurologique _gvol. 160 _gno. 2 _gp. 177-80 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0035-3787(04)70888-7 _zAvailable from publisher's website |
| 999 |
_c14751987 _d14751987 |
||